8-K: Current report
May 1 05:32
10-K/A: Annual report (Amendment)
Apr 30 04:52
8-K: Current report
Apr 20 05:17
424B5: Prospectus
Apr 19 22:13
424B5: Prospectus
Apr 18 20:26
NRX Pharmaceuticals | 8-K: Current report
Apr 16 05:25
NRX Pharmaceuticals | 424B3: Prospectus
Apr 16 05:15
NRX Pharmaceuticals | 424B3: Prospectus
Apr 15 18:28
NRX Pharmaceuticals | 8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Apr 2 18:09
NRX Pharmaceuticals | 10-K: Annual report
Mar 30 05:23
NRX Pharmaceuticals | 8-K: Current report
Mar 29 05:11
NRX Pharmaceuticals | 8-K: Current report
Mar 22 10:20
NRX Pharmaceuticals | DEFA14A: Others
Mar 21 04:03
NRX Pharmaceuticals | DEFA14A: Others
Mar 19 04:01
NRX Pharmaceuticals | DEFA14A: Others
Mar 14 05:10
NRX Pharmaceuticals | DEF 14A: Definitive information statements
Mar 12 05:18
NRX Pharmaceuticals | 8-K: Current report
Mar 7 05:20
NRX Pharmaceuticals | 8-K: Current report
Feb 29 06:25
NRX Pharmaceuticals | 424B5: Prospectus
Feb 28 23:43
NRX Pharmaceuticals | 424B5: Prospectus
Feb 27 06:17
No Data
No Data